Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 81Terminated 14Unknown 7Active not recruiting 6Withdrawn 5Recruiting 5Not yet recruiting 2No longer available 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Neuroblastoma 2Neoplasm Metastasis 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oropharyngeal Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

tislelizumab 2pembrolizumab 2fludarabine phosphate 2fludarabine 2Nivolumab 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2sintilimab 1pegfilgrastim 1liposomal doxorubicin 1Vinorelbine 1Vinblastine 1Specimen Handling 1Radiotherapy 1Proton Therapy 1Neuropsychological Tests 1Gemcitabine 1Fluorodeoxyglucose F18 1Doxorubicin 1Dacarbazine 1Brentuximab Vedotin 1Bendamustine Hydrochloride 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Hodgkin Disease × fludarabine phosphate × Clear all
NCT07164469 2026-06-05

Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma

M.D. Anderson Cancer Center

Phase 2 Not yet recruiting
100 enrolled
Lymphoid

Hodgkin Disease

NCT07444632 2026-05-08

Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase 1 Not yet recruiting
60 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡